VCYT - Veracyte, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
34.2 0.6 (1.75%) --- --- --- --- 0.6 (1.75%) --- ---

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

Category: SERVICES-MEDICAL LABORATORIES
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.01
Diluted EPS:
-0.01
Basic P/E:
-3480.0
Diluted P/E:
-3480.0
RSI(14) 1m:
55.0
VWAP:
34.77
RVol:

Events

Period Kind Movement Occurred At

Related News